General MedicationsINJECTIONGeneric
IFEX/MESNEX KIT
IFOSFAMIDE; MESNA
Standard Dose
1GM/VIAL;100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview IFEX/MESNEX KIT is listed in Drugs@FDA under application 019763 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE; MESNA Form and strength INJECTABLE;INJECTION - 1GM/VIAL;100MG/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2024-12-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview IFEX/MESNEX KIT is listed in Drugs@FDA under application 019763 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient IFOSFAMIDE; MESNA Form and strength INJECTABLE;INJECTION - 1GM/VIAL;100MG/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2024-12-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.